Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade

Author： Marchini Antonio   Scott Eleanor M.   Rommelaere Jean  

Publisher： MDPI

E-ISSN： 1999-4915|8|1|9-9

ISSN： 1999-4915

Source： Viruses, Vol.8, Iss.1, 2016-01, pp. : 9-9

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma

By Ahn Brian J.   Pollack Ian F.   Okada Hideho  

Cancers, Vol. 5, Iss. 4, 2013-11 ,pp. : 1379-1412

MDPI

Access to resources Recommend Favorite

Oncolytic Virotherapy of Canine and Feline Cancer

By Gentschev Ivaylo   Patil Sandeep S.   Petrov Ivan   Cappello Joseph   Adelfinger Marion   Szalay Aladar A.  

Viruses, Vol. 6, Iss. 5, 2014-05 ,pp. : 2122-2137

MDPI

Access to resources Recommend Favorite

Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?

By Mittica Gloria   Genta Sofia   Aglietta Massimo   Valabrega Giorgio  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1169-1169

MDPI

Access to resources Recommend Favorite

From Benchtop to Bedside: A Review of Oncolytic Virotherapy

By Choi Audrey H.   O’Leary Michael P.   Fong Yuman   Chen Nanhai G.  

Biomedicines, Vol. 4, Iss. 3, 2016-08 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?

By Denton Nicholas L.   Chen Chun-Yu   Scott Thomas R.   Cripe Timothy P.  

Biomedicines, Vol. 4, Iss. 3, 2016-07 ,pp. : 13-13

MDPI

Access to resources Recommend Favorite